The impact of refusing esophagectomy for treatment of locally advanced esophageal adenocarcinomaCentral MessagePerspective

Autor: Lye-Yeng Wong, MD, Irmina A. Elliott, MD, Douglas Z. Liou, MD, Leah M. Backhus, MD, Natalie S. Lui, MD, Joseph B. Shrager, MD, Mark F. Berry, MD
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: JTCVS Open, Vol 16, Iss , Pp 987-995 (2023)
Druh dokumentu: article
ISSN: 2666-2736
DOI: 10.1016/j.xjon.2023.09.006
Popis: Objective: Patients with esophageal cancer may be reluctant to proceed with surgery due to high complication rates. This study aims to compare outcomes between eligible surgical candidates who proceeded with surgery versus those who refused surgery. Methods: Characteristics and survival of patients with locally advanced (cT3N0M0, cT1-3N+M0) mid-/distal esophageal adenocarcinoma in the National Cancer Database (2006-2019) who either proceeded with or refused surgery after chemoradiotherapy were evaluated with logistic regression, Kaplan–Meier curves, and Cox proportional hazards methods. Results: Of the 13,594 patients included in the analysis, 595 (4.4%) patients refused esophagectomy. Patients who refused surgery were older, had less distance to travel to their treatment facility, were more likely to have cN0 disease, and were more likely to be treated at a community rather than academic or integrated network program, but did not have significantly different comorbid disease distributions. On multivariable analysis, refusing surgery was independently associated with older age, uninsured, lower income, less distance to a hospital, and treatment in a community program versus an academic/research or integrated network program. Esophagectomy was associated with better survival (5-year survival 40.1% [39.2-41] vs 23.6% [19.9-27.9], P
Databáze: Directory of Open Access Journals